Frontiers in Biomaterials Science is a peer-reviewed english-language open-access journal published by Frontiers Media S.A. in Switzerland, operating under an open-access model since 2022. The journal covers Chemical technology: Biotechnology.
Authors are required to pay an article processing charge to publish in Frontiers in Biomaterials Science; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY license (see other journals using this license).
To date, Frontiers in Biomaterials Science has published 59 articles. Articles are minted with DOIs through the prefix 10.3389.
Keywords
nanobiotechnology, regenerative medicine, medical biotechnology, biomaterials
At a glance
- Publisher
- Frontiers Media S.A.
- Country
- Switzerland
- Primary language
- English
- License
- CC BY
- Peer review
- Anonymous peer review
- OA since
- 2022
- DOI prefix
10.3389
ISSN
- electronic
- 2813-3749
Frequently asked questions
Is Frontiers in Biomaterials Science peer-reviewed?
Yes — Frontiers in Biomaterials Science operates a Anonymous peer review review process.
Does Frontiers in Biomaterials Science charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does Frontiers in Biomaterials Science publish?
Frontiers in Biomaterials Science publishes research in Chemical technology: Biotechnology.
What languages does Frontiers in Biomaterials Science accept?
Frontiers in Biomaterials Science accepts manuscripts in English.
What is the ISSN of Frontiers in Biomaterials Science?
ISSN:
2813-3749 (electronic).How do I submit a manuscript to Frontiers in Biomaterials Science?
Submit through the journal's official portal: visit submission page →